Highly experienced biotech executive, with over a quarter of a century of CNS drug discovery experience Beher takes over the role of Chief Executive Officer…
Read More
Appointment underscores FundaMental’s ambition to develop medicines for neurodegenerative diseases based on a breakthrough molecular mechanism Heidelberg, GERMANY, 20 March 2024 - FundaMental Pharma GmbH,…
Read More
Heidelberg, Germany – 17 November 2022 – FundaMental Pharma GmbH (“FundaMental”), a preclinical neuroscience company spun out of Heidelberg University, today announces that it has launched…
Read More
